The AI Health Podcast

Conversations on AI applications in healthcare, biotech and medicine KI-Zusammenfassung

Pranav Rajpurkar, Adriel Saporta, Oishi Banerjee, Marc Robbins Zur Website › Technology · EN · 41 Folgen · zuletzt 26.07.2022

Platz 2964
0 Aufwertungen, 0 Abwertungen
0

Worum es geht

Explore the ways in which AI will transform healthcare, biotech, and medicine through conversations with entrepreneurs, investors and scientists. Hosted by Pranav Rajpurkar and Adriel Saporta. Produced by Oishi Banerjee and Marc Robbins.

Beschreibung des Anbieters, unverändert aus dem Podcast-Feed übernommen.
Pranav Rajpurkar, Adriel Saporta, Oishi Banerjee, Marc Robbins

Anhören

Der Podcast läuft bei diesen Anbietern — der RSS-Feed funktioniert in jeder Podcast-App.

Neueste Folgen

  1. 26.07.2022 · 46 Min. · Staffel 2, Folge 16

    Dr. George Church is a Professor of Genetics at Harvard Medical School and a co-founder of multiple biotech companies. In this wide-ranging interview, he speaks about his work on de-extinction, his vision of a future…

  2. 11.07.2022 · 49 Min. · Staffel 2, Folge 15

    Karandeep Singh, MD, MMSc, is an Assistant Professor of Learning Health Sciences, Internal Medicine, Urology, and Information at the University of Michigan. He speaks with us about bridging the gap between academia and…

  3. 20.06.2022 · 44 Min. · Staffel 2, Folge 14

    Luis Voloch is Co-Founder and Chief Technology Officer at Immunai, which is applying AI to immunology, genomics and drug discovery. He speaks with us about how Immunai is using AI to build a comprehensive,…

  4. 04.04.2022 · 43 Min. · Staffel 2, Folge 13

    Dr. Suchi Saria is the Founder and CEO of Bayesian Health, the John C. Malone Associate Professor of computer science, statistics, and health policy, and the Director of the Machine Learning and Healthcare Lab at Johns…

  5. 21.03.2022 · 45 Min. · Staffel 2, Folge 12

    Dr. Panch is a primary care physician, the Co-Founder of Wellframe, and an instructor at the Harvard T.H. Chan School of Public Health. He speaks with us about Wellframe's work on demystifying complex care regimens,…

  6. 07.03.2022 · 41 Min. · Staffel 2, Folge 11

    Dr. Krishna Yeshwant is Managing Partner of GV. In addition to working with GV since its inception, he has earned degrees in computer science, medicine and business, and he practiced at Brigham and Women’s Hospital in…

  7. 21.02.2022 · 46 Min. · Staffel 2, Folge 10

    Julie Yoo is a General Partner at Andreessen Horowitz where she leads investments in healthcare technology. Prior to joining a16z, Julie was the co-founder, Chief Product Officer, and Board Director at Kyruus, a…

  8. 07.02.2022 · 49 Min. · Staffel 2, Folge 9

    Nan Li is Managing Director of Obvious Ventures, leading investments in computational biology visionaries, AI-driven platforms and intelligent robotics companies. He speaks with us on how AI and advances in physical…

  9. 24.01.2022 · 50 Min. · Staffel 2, Folge 8

    Joshua A. Gordon, M.D., Ph.D. is the Director of the National Institute of Mental Health (NIMH), the lead federal agency for research on mental disorders. He speaks with us about how AI can be used to provide more…

  10. 10.01.2022 · 45 Min. · Staffel 2, Folge 7

    Dr. Susan Athey is the Economics of Technology Professor at Stanford Graduate School of Business and the Associate Director of the Stanford Institute for Human-Centered Artificial Intelligence. She speaks with us about…

Angaben zu den Folgen aus dem Feed des Anbieters. Abspielen beim Anbieter.

Angaben des Anbieters

Älteste Folge im Feed
12/2020 · seit gut 5 Jahren
Typische Länge
45 Min.
Aufbau
Fortlaufende Folgen Neueste zuerst, Folgen einzeln hörbar

Für Podcast-Betreiber

Gehört dir dieser Podcast? Dann weise es nach — danach kannst du Angaben korrigieren, das Widget für deine Website holen und bekommst Bescheid, wenn dein Podcast nominiert wurde oder gewonnen hat.

Ohne Konto geht es über eine E-Mail-Adresse auf der Domain deiner Sendung — das Konto legen wir dabei an. Die anderen Wege brauchen eine Anmeldung.